GILD Stock Lost 1% Yesterday, Gilead Starts Trial for Its Remdesivir Drug
Gilead Sciences (GILD) stock is slightly down despite the progress that the company made in testing of its remdesivir drug that can be used as the coronavirus treatment.Shares of Gilead Sciences Inc (NASDAQ: GILD) slightly dropped yesterday despite the company announcing advancement in its race for a COVID-19 treatment. GILD
Read More